Your browser doesn't support javascript.
loading
Risk of intracranial haemorrhage with combined fibrinolytic and glycoprotein IIb/IIIa inhibitor therapy in acute myocardial infarction. Dichotomous response as a function of age in the GUSTO V trial.
Savonitto, S; Armstrong, P W; Lincoff, A M; Jia, G; Sila, C A; Booth, J; Terrosu, P; Cavallini, C; White, H D; Ardissino, D; Califf, R M; Topol, E J.
Affiliation
  • Savonitto S; Department of Cardiology, Niguarda Hospital, Milan, Italy. stefano.savonitto@fastwebnet.it
Eur Heart J ; 24(20): 1807-14, 2003 Oct.
Article in En | MEDLINE | ID: mdl-14563339
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Recombinant Proteins / Immunoglobulin Fab Fragments / Tissue Plasminogen Activator / Intracranial Hemorrhages / Fibrinolytic Agents / Antibodies, Monoclonal / Myocardial Infarction Type of study: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male Language: En Journal: Eur Heart J Year: 2003 Document type: Article
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Recombinant Proteins / Immunoglobulin Fab Fragments / Tissue Plasminogen Activator / Intracranial Hemorrhages / Fibrinolytic Agents / Antibodies, Monoclonal / Myocardial Infarction Type of study: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male Language: En Journal: Eur Heart J Year: 2003 Document type: Article